HS COVID-related post-traumatic stress disorder (PTSD) experimental treatment trial
Not Applicable
- Conditions
- Post-Traumatic Stress Disorder (PTSD)Mental and Behavioural Disorders
- Registration Number
- ISRCTN52834682
- Lead Sponsor
- King's College London
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
1. Adults > = 18 years
2. Working in NHS Trusts, Primary Care or Social Care between 1st March 2020 and 31st March 2021 covering the three UK waves of the pandemic.
3. Prior, or new, diagnosis of PTSD determined by a PCL-5 score > 32. Confirmed by the Staff Counselling and Wellbeing Service or Post-Incident Pathway, within SLaM.
Exclusion Criteria
1. Currently receiving psychological treatment for PTSD.
2. Not able to provide informed consent.
3. Unwilling to consent to video-recording of therapy sessions for supervisory purposes.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To understand the feasibility and acceptability of FIRST therapy for HSCWs and MHPs. Feasibility and acceptability will be assessed via the qualitative exit interviews and will answer these questions:<br>1. Will HSCWs present for, commence and complete FIRST therapy.<br>2. Do HSCWs find FIRST therapy and referral processes acceptable.<br>3. Do they find the proposed outcome measures acceptable to consent to and complete?<br>4. Are research procedures acceptable?<br>5. How do the therapists (MHPs) experience (i) delivering FIRST and (ii) to HSCWs colleagues.<br>The exit interviews will take place at four weeks’ post end-of-therapy delivery and qualitative content analysis will be applied to the data.<br>
- Secondary Outcome Measures
Name Time Method Mental health outcomes collected at baseline and four weeks’ post end-of-therapy; and PCL-5 and GAD-7 will also be collected at completion of therapy (approx. four weeks’ post baseline):<br>1. Post-traumatic Stress Disorder Checklist (PCL-5)<br>2. Work and Social Adjustment Scale (WSAS)<br>3. Patient Health Questionnaire (PHQ-9)<br>4. The General Anxiety Disorder (GAD-7)<br>5. The EuroQol five-dimensional five-levels (EQ-5D-5L)<br>6. The EuroQol-visual analogue scale (EQ-VAS)<br>